Most diseases are recognised by clinical, chemical, radiological, or pathological features present in that disease but not in other diseases or in normal people. Pernicious anaemia, cancer, stroke, and tuberculosis are diagnosed in this way. Essential hypertension is unusual in that apart from raised arterial pressure it has no characteristic or positive features. Diagnosis is reached negatively by exclusion of alternative diagnoses. A normal intravenous pyelogram is needed because an abnormal result suggests a renal cause for hypertension. Normal cortisol, catecholamines, aldosterone, and renin exclude other secondary forms of hypertension.
This process of elimination would be justified if all patients excluded suffered from a disease qualitatively different from essential hypertension. We suggest here that two of the conditions excluded are not and that their exclusion alters the investigator's view of essential hypertension. The evidence is based partly on a recent analysis (Davies et al., 1979) and partly on other work.
Patients and methods
Data from 117 hypertensive patients and 37 normal individuals were included in the original analysis (Davies et al., 1979) . All were studied in our wards while having a known dietary intake of sodium and potassium within the normal range. Measurements were made of blood pressure, exchangeable sodium and potassium, and plasma concentration of electrolytes, total renin, angiotensin II, and aldosterone. Details of the patients and tests are given in the earlier paper (Davies et al., 1979) . For the purpose of the analysis, patients with a diastolic blood pressure of 100 mmHg or more on two or more occasions before admission to the ward were considered hypertensive. All had a normal intravenous pyelogram and were without clinical or biochemical evidence of Cushing's syndrome or phaeochromocytoma. Hypertensive patients were considered in four groups: GROUP I Twenty-eight patients had primary hyperaldosteronism with an adrenal adenoma (Conn's syndrome) confirmed in each by surgery and histological examination of the adrenal cortex (Ferriss et al., 1978a and b) . Other findings are given in Table 1 and in Davies et al. (1979) .
GROUP II
Seventeen patients had idiopathic" hyperaldosteronism (Liddle, 1967) or primary hyperaldosteronism without adenoma. Absence of an adenoma was established in three by subtotal adrenalectomy v.. ith histological examination of the adrenal cortex. In the remainder, the statistical technique of quadric analysis was used to distinguish the two forms of hyperaldosteronism preoperatively (Ferriss et aI., 1979b) .
GROUP III
Fifty-six patients had essential hypertension with normal renin, that is, a mean of all estimates of the plasma concentration of total renin in individual patients above 38 ul.Jnits/rnl.
GROUP IV
Sixteen patients had low-renin essential hypertension, sharing all features with group III except that mean total renin concentration in plasma for each subject was equal to or less than 38~Units/ml Davies et al., 1979) .
Plasma aldosterone concentration was measured in every patient in the four groups on two or more occasions. In patients of groups I and II, plasma aldosterone was above the upper limit of normal (18 ng/l00 ml) on two or more occasions (Davies et al., 1979) . In patients of groups III and IV, plasma aldosterone concentration was consistently normal, except in one patient in whom the aldosterone concentration was increased on one occasion ·Another term is 'prtm arv' or 'Jew-renin hyperaldostercnhm without tumour". (reasons for including this patient as essential hypertension are explained below).
Stimuli to aldosterone in normal subjects Figure 1 and Table 1 give data for normal subjects. Individuals having normal, low, and high dietary sodium intake are included in this part of the analysis (see Davies et al., 1979) . Exchangeable sodium correlated negatively with aldosterone as would be expected if sodium loss was stimulating aldosterone secretion . Exchangeable sodium also correlated negatively with renin, renin positively with angiotensin II, and angiotensin II positively with aldosterone ( Fig. 1 ), all suggesting that part of the stimulant effect of sodium loss was exerted through the renin-angiotensin system. The weak but significant positive correlation of plasma potassium concentration with aldosterone further suggests that increased potassium is an additional stimulus to aldosterone in normal subjects. There is other evidence for this Himathongkam et al., 1975) .
Primary hyperaldosteronism with tumour (Conn's syndrome) Figure 2 shows the quite different pattern of correlations found in Conn's syndrome. Aldosterone now correlates positively with exchangeable sodium; presumably autonomous oversecretion of aldosterone from the tumour produces sodium retention (see Table 1 ). Probably because of this, renin and angiotensin II concentrations are low ( Fig. 2 Davies et al., 1979 ). ·p<O·05; ··p<O·01;
···p<O·001.
aldosterone and angiotensin II reverses from its normal positive state to become significantly negative ( Figs. 2 and 3) . The reversal implies that, through sodium retention, angiotensin II production is being governed by aldosterone rather than the opposite, which seems to apply in normal subjects ( (Fig. 3 ). This suggests that aldosterone excess in idiopathic hyperaldosteronism is not primary. Another explanation for the correlation will be discussed shortly, Also, in contrast with Conn's syndrome, exchangeable sodium was not raised significantly, and exchangeable potassium was not decreased in idiopathic hyperaldosteronism ( Table 1) . We and others have been able to separate the two forms of primary hyperaldosteronism using biochemical and clinical criteria (Baer et al., 1970; Biglieri et al., 1972; Luetscher et al., 1974; Ferriss et al., 1978a) . The ease and reliability with which the separation can be made, together with the bimodal distribution of data ( Fig. 4) , suggest that the two conditions are qualitatively different. We shall return to this shortly. Meanwhile, one possibility needing consideration is that non-adenomatous hyperaldosteronism is a precursor of Conn's syndrome, that the nodules commonly found grow to become adenomata. Several points are against the idea: nodules and tumours are histologically distinct also reverses in Conn's syndrome to become the opposite of normal (Fig. 2) , that is, increasing aldosterone is associated with decreasing potassium.
Reversal of a normally positive relation between stimulus and hormone may be a hallmark of excess hormone secretion arising either primarily within the gland or as a result of strong stimulation by another external agent (Davies et al., 1979) . Other features of Conn's syndrome are well known (Ferriss et al., 1978a and b) and were seen in the present analysis: a slight increase of plasma sodium concentration, a marked increase of exchangeable sodium, and a decrease of exchangeable and plasma potassium ( Table I ).
-0.'. a.:~n~.,. • is of a diagnosis based on positive features, qualitatively and quantitatively different from those in normal subjects and in essential hypertension (Tables I and 2 ). All that can be said of idiopathic hyperaldosteronism, on the evidence considered so far, is that it may not be primary and that it is readily distinguished from Conn's syndrome (Tables  I and 2) .
Essential hypertension with normal renin Plasma and exchangeable sodium concentrations and plasma and exchangeable potassium concentrations were close to normal in essential hypertension (Table 1) . Correlations within the reninaldosterone mechanism were unremarkable, like those in idiopathic hyperaldosteronism but unlike those in Conn's syndrome and in normal subjects. None of the correlations between exchangeable sodium, renin, aldosterone, or exchangeable potassium reached significance. Lack of numbers was not responsible for the insignificance since more data were available for this than for any other analysis. The most interesting finding to emerge was the relation between plasma concentrations of angiotensin II and aldosterone (Fig. 5 ). Many patients with essential hypertension have a plasma concentration of aldosterone which is higher for a given level of angiotensin II than that found in normal subjects. Angiotensin II concentrations did not correlate significantly with aldosterone concentrations. 82,660-671.1971 . We thank the editors of the American Heart Journal for permission to publish the figure. (Ferriss et al., 1978a; Neville, 1978; Neville and O'Hare, 1979) and patients with idiopathic hyperaldosteronism tend to be older and to have higher blood pressure than patients with Conn's syndrome (Ferriss et al., 1978a; Davies et al., 1979) .
Low-renin hypertension
The impression of Conn's syndrome, therefore, Between 10 and 20 % of patients with essential hypertension have reduced plasma renin activity or plasma renin concentration and are said to have low-renin hypertension (Kaplan, 1973; Dunn and Tannen, 1974; Padfield et al., 1975a; Wiedmann et al., 1978) . One explanation offered is that lowrenin hypertension is qualitatively different from essential hypertension and that it results from excess mineralocorticoid, other than aldosterone, producing sodium retention with hypertension. Renin is then suppressed by the sodium retention (Carey et al., 1972) . Against the idea is the absence in our experience of sodium retention and volume expansion (Table 1 ; see also Lebel et al., 1974; , and the failure, so far, to demonstrate excess mineralocorticoid in more than a small proportion of patients. r=O'] 6 p>OOS
We favour an alternative explanation: that lowrenin hypertension is an artefact produced by application of the normal range to a wider than normal distribution of renin in essential hypertension (Padfield et 'II., 1975a) . The frequencydistributions of plasma renin concentration (Padfield et al., 1975a) , plasma renin activity (Thomas et al., 1978; Thurston et al., 1978) , and plasma angiotensin II concentration (Beevers et al., 1977) are broader than normal in essential hypertension. An explanation for, the reduced renin concentration is that renin decreases with age in essential hypertension (Schalekamp et al., 1970; Hayduk et al., 1973; Tuck et al., 1973; Wiedmann et al., 1978) , and that the decrease is greater than that which occurs in normal subjects during the same period (Hayduk et al., 1973; Wiedmann et al., 1978) . Thus, low-renin hypertension may be no more than an advanced stage of essential hypertension, or essential hypertension developing in elderly patients Dunn and Tannen, 1974; Padfield et al., 1975b) . It can be seen in Fig. 5 that low-renin hypertension and essential hypertension with normal renin share the same abnormal relation between angiotensin II and aldosterone. Plasma aldosterone concentration is high relative to angiotensin II in both conditions. and during infusion of angiotensin II in normal subjects and in patients with essential hypertension, The second panel shows the relation between angiotensin l/ and the plasma concentration of 18-0H corticosterone in the same subjects before and during infusion of angiotensin Il, There were 11 normal subjects and six essential hypertensive patients in the experiment.
Abnormal relation of angiotensin II and aldosterone in essential hypertension
Collins and his colleagues (1970) have found aldosterone concentration to be high relative to renin activity in essential hypertension. The response of aldosterone to infused angiotensin II is also abnormally brisk (Kisch et al., 1976; Wisgerhof and Brown, 1978; Brown et al., 1979; Davies et al., 1979) . Our own data show that for a given plasma concentration of angiotensin II, and for a given increment in plasma concentration, aldosterone increases more in essential hypertension than it does in normal subjects (Fig. 6) . The concentration of 18-0H corticosterone, a possible precursor of aldosterone, also increases more in essential hypertension than in normal subjects (Fig. 6) . These observations suggest that the altered relation of angiotensin II and aldosterone in essential hypertension is a consequence of the brisk response to angiotensin II rather than a manifestation of excess aldosterone with secondary suppression of renin and angiotensin II, such as occurs in Conn's syndrome. An important point of distinction is that the response of aldosterone to infused angiotensin II is subnormal in Conn's syndrome (Mason et al., 1978; Brown et al., 1979) . Thus in terms of their response, to angiotensin II, idiopathic hyperaldosteronism, low-renin hypertension, and essential hypertension are similar to each other but markedly different from Conn's syndrome (Table 2 , see also Kisch et al., (1976) , Brown and Wisgerhof (1978) , Davies et al., (1979) and Brown et al. (1979) ).
The existence of an abnormal relation between angiotensin II and aldosterone could have important consequences for the classification of hypertension. If normal ranges for renin for angiotensin II and for aldosterone concentrations are applied to a group of patients having this abnormal relation, together with wider than normal ranges of renin and aldosterone, two syndromes will appear to separate from essential hypertension. Both will mimic mineralocorticoid excess in having a plasma concentration of renin or angiotensin II which is low for a given level of aldosterone. One, with increased aldosterone, will be considered 'primary' hyperaldosteronism because of its resemblance to Conn's syndrome. The other, with subnormal renin and normal aldosterone, will be classified as 'low-renin' hypertension. If this is correct and if Conn's syndrome is genuinely different from essential hypertension we would expect the distinction of primary hyperaldosteronism with and without tumour to be clearer than the distinction of nontumorous primary hyperaldosteronism and essential hypertension. Table 2 summarises the main features distinguishing the three conditions. As noted earlier, the ease with which the two forms of primary hyperaldosteronism can be distinguished suggests that they are qualitatively different. In contrast, none of these features suggests a further distinction between idiopathic hyperaldosteronism and essential hypertension ( Table 2) . Pathological manifestations of essential hypertension and idiopathic hyperaldosteronism are similar: nodules of the adrenal cortex are common in both (Dobbie, 1969; Neville, 1978) ; hyperplastic change sometimes occurs in the adrenal cortex in idiopathic hyperaldosteronism, but it has also been reported in low-renin hypertension (Gunnels et al., 1970) . Other features absent in Conn's syndrome but shared by essential hypertension and idiopathic hyperaldosteronism include the negative correlation of renin with age, the abnormally brisk response of aldosterone to upright posture and to infused angiotensin II, the lack of significant correlations within the renin-aldosterone-sodium mechanism, and the lack of signs of mineralocorticoid excess, notably sodium retention and potassium depletion (Tables 1 and 2) .
Distinction of primary hyperaldosteronism without tumour and essential hypertension
Even the criterion of aldosterone excess, a plasma aldosterone above 18 ngjloo ml on two or more occasions, is questionable. It will be seen in Table 1 that the mean plasma aldosterone concentration was 32·7 ngjloo ml in Conn's syndrome, 15·9 ngjloo ml in idiopathic hyperaldosteronism, and 10·6 ngj 100 ml in essential hypertension. Thus, the average aldosterone concentration for idiopathic hyperaldosteronism is within the normal range. This occurs because aldosterone was measured on as many as six occasions in some patients (including occasions not part of this study), and only two estimates need be above normal for a patient to qualify as having hyperaldosteronism. As can be seen in Fig. 3B , aldosterone was often within the normal range, and this also sometimes occurs in Conn's syndrome (Fig. 3A) . It follows that increasing the number of measurements made will increase the chance of hyperaldosteronism being diagnosed in a patient with intermittent aldosterone excess. Different criteria could have been used; a mean of all estimates of aldosterone above the upper limit of normal is another possible criterion. But even here, some patients with essential hypertension will have two or more values of aldosterone above the upper limit of normal and yet have a mean within the normal range. The dilemma for the clinician, therefore, is whether to accept that aldosterone excess is an occasional feature of essential hypertension (Collins et al., 1970; Genest et al., 1977; Wiedmann et al., 1978) or to exclude all cases at the first sign of aldosterone excess. We have tended, perhaps wrongly, towards the second policy. In our view, the problem lies not in the need for better diagnostic criteria but in the false expectation that any arbitrary criterion will clearly distinguish two parts of a continuous distribution.
We conclude that the separation of essential hypertension and idiopathic hyperaldosteronism has no firm basis and that they are more likely to be parts of the same condition than different conditions. If this conclusion is correct, exclusion of patients with excess aldosterone or low renin will obscure the true nature of essential hypertension. To confine an investigator's attention to patients with normal aldosterone, because it is assumed that excess aldosterone is a different state, cannot increase understanding of either hyperaldosteronism or essential hypertension. We do not imply by this that excess aldosterone is an explanation for essential hypertension, merely that it is an occasional and potentially important finding.
Until 1969 most of our patients with primary hyperaldosteronism were subjected to operation; if a tumour was found unilateral adrenalectomy was done; if a tumour was not found subtotal adrenalectomy was sometimes done. Since 1969 we have been able to distinguish the two forms of disease preoperatively (Ferriss et al., 1978b) and surgery has been undertaken only where a tumour was strongly suspected. In the light of our present views, was subtotal adrenalectomy for idiopathic hyperaldosteronism a mistake? In the event, it frequently lowers blood pressure (Biglieri et al., 1970; Ferriss et al., 1975) . Subtotal adrenalectomy has also been done in patients with low-renin hypertension and here again blood pressure usually falls (Gunnels et al., 1970 ). However, the success of subtotal adrenalectomy does not necessarily imply that the initial elevation of blood pressure was caused by overactivity of the adrenal cortex. Removal of the cortex is likely to reduce blood pressure somewhat in any form of hypertension. All that can be said, if we are correct, is that there is not more justification for operating on patients with idiopathic hyperaldosteronism than there is for operating on essential hypertension. Probably surgery is justified in neither since medical treatment is usually effective.
Postscript: Distinction of normal and abnormal blood pressure
The argument advanced in this paper closely resembles Pickering's (1978) views on the nature of essential hypertension: because blood pressure has a continuous frequency distribution in the general population, he argues, an attempt to separate normal and abnormal blood pressure by an arbitrary dividing line is unjustified and misleading. A dividing line leads to a mistaken belief that hypertension is qualitatively different from normal. We agree with this view, as do many others. The point we make here is that within essential hypertension two arbitrary dividing lines have been drawn: one in the frequency distribution of renin, the other in the frequency distribution of aldosterone. They are responsible for the mistaken belief in the existence of two conditions which are qualitatively different from essential hypertension.
